Cite
Ng SP, Pollard C, Kamal M, et al. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol. 2019;3:22doi: 10.1038/s41698-019-0097-y.
Ng, S. P., Pollard, C., Kamal, M., Ayoub, Z., Garden, A. S., Bahig, H., Gunn, G. B., Frank, S. J., Skinner, H. D., Phan, J., Berends, J., Morrison, W. H., Johnson, J. M., Ferrarotto, R., Sturgis, E. M., Mohamed, A. S. R., Lai, S. Y., Fuller, C. D., & Rosenthal, D. I. (2019). Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ precision oncology, 322. https://doi.org/10.1038/s41698-019-0097-y
Ng, Sweet Ping, et al. "Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy." NPJ precision oncology vol. 3 (2019): 22. doi: https://doi.org/10.1038/s41698-019-0097-y
Ng SP, Pollard C, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol. 2019 Sep 27;3:22. doi: 10.1038/s41698-019-0097-y. eCollection 2019. PMID: 31583278; PMCID: PMC6764977.
Copy
Download .nbib